impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
Published 5 years ago • 153 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
2:30
impassion130: immunotherapy for tnbc
-
4:27
the impassion130 study in metastatic tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
2:33
applying impassion130 data to tnbc management
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
4:56
results from the impassion 130 trial treating metastatic breast cancer
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
4:47
tnbc: updated efficacy results from impassion130
-
1:07
phase ii results for pembrolizumab monotherapy in metastatic tnbc
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
3:33
eribulin in metastatic tnbc: real-world data
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
3:45
immunotherapy for tnbc